Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2007-08-14
2007-08-14
Schnizer, Richard (Department: 1635)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S458000, C530S328000, C530S317000, C530S323000, C530S326000, C536S023100
Reexamination Certificate
active
10471895
ABSTRACT:
The invention provides a peptide having at least 3 amino acids comprising an amino acid sequence selected from a) X1SM [SEQ.ID.NO.:1] b) LX2HK [SEQ.ID.NO.:2] c) PSGX3ARA [SEQ.ID.NO.:9] d) SX4RSMNF [SEQ.ID. NO.:16] e) LX5HKSMP [SEQ.ID.NO.:18] in which X is a basic amino acid residue, X1is Q or P, X2is A or T, X3is an acidic amino acid residue and X4is P or Q, the invention further provides non-viral cell-targeting vector complexes and methods associated therewith.
REFERENCES:
patent: 0 819 758 (1998-12-01), None
patent: WO 98/54347 (1998-12-01), None
patent: WO 00/25814 (2000-05-01), None
patent: WO 00/62815 (2000-10-01), None
patent: WO 00/75174 (2000-12-01), None
Verma et al (Nature 389: 239-242, 1997).
Anderson (Nature 392:25-30, 1998).
Romano et al (Stem Cells 18: 19-39, 2000).
Somia and Verma (Nature Reviews Genetics 1: 91-99, 2000).
Rosenberg et al, Science 287:1751, 2000.
Juengst (BMJ 326: 1410, 2003).
Rosenfeld and Collins (Chest 109:241-252, 1996).
Ferrari et al (Adv. Drug Del. Rev 54:1373-1393, 2002).
Boucher (TIG 12(3): 81-84, 1996).
Rosenecker (Eur. J. Med. 23(3): 149-156, Mar. 1998).
Wilson (J. Clin. Invest 96: 2547-2554, 1995).
Boucher (J. Clin. Invest. 103(4): 441-445 Feb. 1999).
Alton and Geddes (J. R. Soc. Med 90 Suppl 31: 43-46 1997).
Davies (Mol. Med Today 4(7): 292-299, Jul. 1998).
Barouch et al (Intervirology 2000 43: 282-287).
Bende et al (AIDS Read. 10(9): 526-528, 530-532 (Sep. 2000).
Peters (Vaccine 20: 688-705, 2002).
Crook (In Basic Principles of Antisense Therapeutics, Springer-Verlag, Eds, New York, 1998, pp. 1 and 4).
Branch (Trends in Biochem. Sci 23: 45-50, 1998).
Ho and Parkinson (Sem. Drug Discov. 24(2): 187-202, 1997).
Akhtar (J. Antimicrob. Chemother. 38(2): 159-165, 1996).
Steadman's Medical Dictionary (26th Edition, 1995) pp. 522 and 1340.
1998/99 New England Biolabs catalog (pp. 140 and 141).
GenBank Accession No. AAN81395.1, Apr. 20, 2006.
Almeida et al.,Cell, 81:1095-1104 (1995).
Anderson et al.,Human Gene Therapy, 8:1125-1135 (1997).
Barry et al.,Nature Medicine, 2(3):299-305 (1996).
Bergelson et al.,Science, 255:1718-1720 (1992).
Bettinger et al.,Bioconjugate Chem., 10:558-561 (1999).
Blank et al.,The Journal of Cell Biology, 107:299-306 (1988).
Blattner et al.,Science, 277:1453-1462 (1997).
Brunner et al.,Gene Therapy, 7:401-407 (2000).
Clements et al.,Journal of Cell Science, 107:2127-2135 (1994).
Cotten et al.,Proc. Natl. Acad. Sci. USA, 87:4033-4037 (1990).
Curiel et al.,Proc. Natl. Acad. Sci. USA, 88:8850-8854 (1991).
Farhood et al.,Biochimica et Biophyisca Acta, 1235:289-295 (1995).
Feero et al.,Gene Therapy, 4:664-674 (1997).
Ferkol et al.,J. Clin. Invest., 95:493-502 (1995).
Fernańdez et al.,Eur. J. Immunol., 23:552-557 (1993).
Feuillet et al.,Proc. Natl. Acad. Sci. USA, 96:8265-8270 (1999).
Haberland et al.,Biochimica et Biophyisca Acta, 1445:21-30 (1999).
Han et al.,Biol. Pharm. Bull., 22(8):836-840 (1999).
Hart et al.,The Journal of Biological Chemistry, 269(17):12468-12474 (1994).
Hart et al.,Gene Therapy, 2:552-554 (1995).
Hart et al.,Gene Therapy, 4:1225-1230 (1997).
Hart et al.,Human Gene Therapy, 9:575-585 (1998).
Healy et al.,Biochemistry, 34:3948-3955 (1995).
Hendrix et al.,Proc. Natl. Acad. Sci. USA, 96:2192-2197 (1999).
Hsieh et al.,Journal of Cellular Biochemistry, 70:94-109 (1998).
Isberg et al.,Science, 252:934-938 (1991).
Kohli et al.,Virology, 194:110-116 (1993).
Koivunen et al.,The Journal of Biological Chemistry, 268(27):20205-20210 (1993).
Koivunen et al.,The Journal of Cell Biology, 124(3):373-380 (1994).
Koivunen et al.,Biotechnology, 13:265-270 (1995).
Logan et al.,Nature, 362:566-569 (1993).
Lu et al.,Biochem. J., 296:21-24 (1993).
Mahata et al.,Molecular Endocrinology, 14(10):1525-1535 (2000).
Massia et al.,The Journal of Biological Chemistry, 267(20):14019-14026 (1992).
Nicklin et al.,Circulation, 102:231-237 (2000).
O'Neil et al.,Proteins: Structure, Function, and Genetics, 14:509-515 (1992).
Park et al.,Hybridoma, 18(6):487-495 (1999).
Pasqualini et al.,The Journal of Cell Biology, 130(5):1189-1196 (1995).
Pasqualini et al.,Molecular Psychiatry, 1:423 (1996).
Pasqualini et al.,Nature, 380:364-366 (1996).
Phillips et al.,Biologicals, 23:13-16 (1995).
Pierschbacher et al.,Nature, 309:30-33 (1984).
Reddy et al.,Journal of Pharmaceutical Sciences, 88(11):1112-1118 (1999).
Reddy et al.,Journal of Controlled Release, 64:27-37 (2000).
Relman et al.,Cell, 61:1375-1382 (1990).
Samoylova et al.,Muscle&Nerve, 22:460-466 (1999).
Schneider et al.,FEBS Letters, 429:269-273 (1998).
Staatz et al.,The Journal of Biological Chemistry, 266(12):7363-7367 (1991).
Tseng et al.,Biochimica et Biophysica Acta, 1445:53-64 (1999).
Uherek et al.,The Journal of Biological Chemistry, 273(15):8835-8841 (1998).
Velucchi et al.,Vaccines, 94:141-146 (1994).
Verfaillie et al.,Blood, 84(6):1802-1811 (1994).
Wagner et al.,Bioconjugate Chem., 2:226-231 (1991).
Wang et al.,Proc. Natl. Acad. Sci. USA, 92:5714-5718 (1995).
Wang et al.,Journal of Virology, 72(12):9818-9826 (1998).
Wang et al.,Am. J. Respir. Cell Mol. Biol., 22:129-138 (2000).
Wickham et al.,The Journal of Cell Biology, 127(1):257-264 (1994).
Wilke et al.,Gene Therapy, 3:1133-1142 (1996).
Wolfert et al.,Gene Therapy, 3:269-273 (1996).
Wu et al.,The Journal of Biological Chemistry, 262(10):4429-4432 (1987).
Wu et al.,The Journal of Biological Chemistry, 266 (22):14338-14342 (1991).
Yano et al.,Human Gene Therapy, 11:995-1004 (2000).
Zhang et al.,Gene Therapy, 6:171-181 (1999).
Hart Stephen Lewis
Writer Michele
ICH Productions Limited
Schnizer Richard
Wesolowski Michael R.
Yankwich Leon R.
Yankwich & Associates P.C.
LandOfFree
Transfection complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transfection complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transfection complexes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3884055